Opportunity Information: Apply for CDC RFA PS10 1075
Apply for CDC RFA PS10 1075
- The Centers for Disease Control and Prevention in the health sector is offering a public funding opportunity titled "Improving Health Care Practices in the Context of Infection Prevention and Control in Central Asian Republics of Kazakhstan, Kyrgyz Republic, Uzbekistan, Tajikistan, and Turkmenistan Under the President s Emergency Plan for AIDS Relief (PEPFAR)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.067 Global AIDS.
- This funding opportunity was created on Apr 26, 2010 and posted on Mar 15, 2010.
- Applicants must submit their applications by May 17, 2010. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $5,000,000.00 to eligible and selected applicants.
- Each selected applicant is eligible to receive up to $5,000,000.00 in funding.
- The number of recipients for this funding is limited to 1 candidate(s).
- Eligible applicants include: Small businesses For profit organizations other than small businesses Special district governments State governments Others (see text field entitled Additional Information on Eligibility for clarification) Private institutions of higher education Public and State controlled institutions of higher education Native American tribal governments (Federally recognized) Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education.
- Eligible applicants that can apply for this funding opportunity are listed below Public nonprofit organizations Private nonprofit organizations For profit organizations Small, minority, women owned business Universities Colleges Research institutions Hospitals Community based organizations Faith based organizations Federally recognized Indian tribal organizations Alaska Native tribal governments Indian tribes Tribal Epidemiology centers Indian tribal organizations State and local governments or their Bona Fide Agents (this includes the District of Columbia, the Commonwealth of Puerto Rico, the Virgin Islands, the Commonwealth of the Northern Marianna Islands, American Samoa, Guam, the Federated States of Micronesia, the Republic of the Marshall Islands, and the Republic of Palau) Political subdivisions of States (in consultation with States) Non domestic (non U.S.) entity Other (specify) A Bona Fide Agent is an agency/organization identified by the state as eligible to submit an application under the state eligibility in lieu of a state application. If applying as a bona fide agent of a state or local government, a letter from the state or local government as documentation of the status is required. Attach with Other Attachment Forms when submitting via www.grants.gov.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
This funding opportunity (CDC RFA PS10-1075) is a CDC cooperative agreement under PEPFAR focused on strengthening infection prevention and control (IPC) in health care settings across five Central Asian republics: Kazakhstan, the Kyrgyz Republic, Tajikistan, Turkmenistan, and Uzbekistan. The core aim is to reduce the risk of health care-associated transmission of HIV and other bloodborne infections by improving how injections and other invasive procedures are performed, standardized, taught, supervised, and sustained within national health systems. Rather than simply supplying commodities, the emphasis is on technical assistance that leads to measurable changes in clinical practice and formal adoption of safer procedures by host governments.
The program is centered on improving safe injection practices and closely related procedures that involve exposure to blood or sharp instruments. While injections are the headline focus, the scope explicitly includes other common clinical activities such as phlebotomy and blood drawing, as well as intravascular catheter use and similar procedures where poor technique, inadequate sterilization, or unsafe handling and disposal of sharps can lead to infection risks for patients and health care workers. In practical terms, the grant is designed to help countries implement modern IPC approaches that reduce unnecessary injections, promote correct aseptic technique, ensure appropriate use and handling of needles and syringes, and reinforce safe sharps management and waste disposal practices.
A key feature of the opportunity is the use of demonstration or pilot implementation sites. The funded partner is expected to show successful, real-world implementation of safe injection and related IPC procedures at selected pilot sites and use those sites as proof of concept for broader national uptake. The intent is that these pilots do not remain isolated projects; they should be structured to support replication and scale-up, with clear documentation of what was changed, how it was implemented, and what results were achieved. This approach is meant to help host governments see workable models within their own systems and then formalize those models into standard practice.
Another major deliverable is workforce development through training materials and incorporation into existing national training systems. The award expects the recipient to develop new training resources and/or adapt existing materials so that host governments can integrate them into their own ongoing training programs for health care workers. That typically implies creating practical curricula, job aids, standard operating procedures, and training-of-trainers approaches that can be maintained locally after the external technical assistance ends. The focus is not only on one-time trainings, but on embedding competencies into routine pre-service and in-service education and supervision structures.
In parallel with site-level implementation and training, the program is also intended to support national-level policy and planning. Specifically, the recipient is expected to assist with developing and/or modifying each host government’s national injection safety plan and related procedural guidance within the broader context of infection prevention and control. This reflects a systems-level goal: aligning national standards, guidelines, and implementation plans with evidence-based practices so that safer procedures become institutional requirements rather than optional recommendations. In many settings, this kind of plan revision also drives procurement standards, supervision checklists, reporting requirements, and accountability mechanisms.
Applicants are encouraged to propose work in as many of the five countries as feasible, but the final country assignment and the exact mix of activities are determined at the time of award. This means an application can present a multi-country strategy, yet should also be prepared for CDC to prioritize specific countries or tailor the portfolio depending on program needs, feasibility, and available resources. The expectation of flexibility is consistent with the cooperative agreement model, which generally involves substantial federal involvement and ongoing collaboration between CDC and the recipient during implementation.
From a funding standpoint, the opportunity projected a single award (ExpectedAwards: 1) with an estimated total funding level of up to USD 5,000,000, with an award ceiling of USD 5,000,000 and no stated minimum (award floor USD 0). There is no cost sharing or matching requirement. The activity falls under the health category and is tied to CFDA 93.067 (Global AIDS), reinforcing that the work is positioned as part of PEPFAR’s broader goals to prevent HIV transmission and strengthen health systems where blood exposure risks exist.
Eligibility is broad and includes public and private nonprofits, for-profit organizations (including small businesses and minority or women-owned businesses), universities and colleges, research institutions, hospitals, community-based and faith-based organizations, federally recognized tribal entities and related organizations, and state and local governments or their bona fide agents. Non-U.S. (non-domestic) entities are also listed as eligible. For applicants applying as a bona fide agent of a state or local government, documentation (a letter confirming that status) is required as part of the submission. Overall, this wide eligibility reflects CDC’s interest in selecting an organization with strong technical capacity in IPC, clinical quality improvement, training system development, and multi-country program implementation.
Administratively, the opportunity was posted March 15, 2010, with a closing date of May 17, 2010, and an archive date of June 16, 2010. The sponsoring agency is the Centers for Disease Control and Prevention, and questions about accessing the full announcement were directed to the CDC Procurement and Grants Office Technical Information Management Section. The structure and stated deliverables indicate the award was meant to catalyze practical improvements in clinical safety, translate those improvements into government-owned standards and training, and ultimately reduce infection risks associated with injections and other invasive procedures across targeted Central Asian health systems.
FAQs: CDC RFA PS10-1075 (PEPFAR) - Infection Prevention and Control in Central Asia
What is CDC RFA PS10-1075?
CDC RFA PS10-1075 is a CDC cooperative agreement under PEPFAR focused on strengthening infection prevention and control (IPC) in health care settings. The effort is designed to reduce health care-associated transmission risks for HIV and other bloodborne infections.
What is the main purpose of this funding opportunity?
The core aim is to reduce the risk of health care-associated transmission of HIV and other bloodborne infections by improving how injections and other invasive procedures are performed, standardized, taught, supervised, and sustained within national health systems.
Which countries are included in the program scope?
The opportunity targets five Central Asian republics: Kazakhstan, the Kyrgyz Republic, Tajikistan, Turkmenistan, and Uzbekistan.
Is this grant primarily meant to purchase supplies (commodities)?
No. The emphasis is on technical assistance that leads to measurable changes in clinical practice and formal adoption of safer procedures by host governments, rather than simply supplying commodities.
What types of clinical practices are the main focus?
The program is centered on improving safe injection practices and closely related procedures involving exposure to blood or sharps. While injections are the headline focus, the scope explicitly includes phlebotomy and blood drawing, intravascular catheter use, and similar procedures where unsafe technique or sharps handling can increase infection risks.
What kinds of improvements is the program intended to support in practice?
The grant is designed to help countries implement modern IPC approaches that reduce unnecessary injections, promote correct aseptic technique, ensure appropriate use and handling of needles and syringes, and reinforce safe sharps management and waste disposal practices.
What are demonstration or pilot implementation sites, and why are they important?
A key feature is the use of demonstration or pilot implementation sites. The funded partner is expected to show successful, real-world implementation of safe injection and related IPC procedures at selected pilot sites and use those sites as proof of concept for broader national uptake.
Are pilot sites expected to remain small, standalone projects?
No. The intent is that pilot efforts should be structured to support replication and scale-up, with clear documentation of what was changed, how it was implemented, and what results were achieved so host governments can adopt and formalize workable models.
What role does training and workforce development play in this award?
Workforce development is a major deliverable. The recipient is expected to develop new training resources and/or adapt existing materials so host governments can integrate them into ongoing training programs for health care workers.
What types of training resources may be developed under this opportunity?
The opportunity describes resources such as practical curricula, job aids, standard operating procedures, and training-of-trainers approaches, with an emphasis on materials that can be maintained locally.
Is the goal to conduct one-time training events?
No. The focus is on embedding competencies into routine pre-service and in-service education and supervision structures so safer practices are sustained beyond the period of external technical assistance.
Does the program include national policy and planning support?
Yes. The recipient is expected to assist with developing and/or modifying each host government’s national injection safety plan and related procedural guidance within the broader context of infection prevention and control.
How does revising a national injection safety plan support long-term change?
The opportunity describes a systems-level goal: aligning national standards, guidelines, and implementation plans with evidence-based practices so safer procedures become institutional requirements rather than optional recommendations.
Are applicants expected to work in all five countries?
Applicants are encouraged to propose work in as many of the five countries as feasible, but the final country assignment and the exact mix of activities are determined at the time of award.
How much funding is available under this opportunity?
The opportunity projected a single award with an estimated total funding level of up to USD 5,000,000. The award ceiling is USD 5,000,000, and there is no stated minimum (award floor USD 0).
How many awards does CDC expect to make?
The funding opportunity projected a single award (ExpectedAwards: 1).
Is cost sharing or matching required?
No. The announcement states there is no cost sharing or matching requirement.
What program and funding classification is associated with this opportunity?
The activity is in the health category and is tied to CFDA 93.067 (Global AIDS), positioning the work as part of PEPFAR’s broader goals to prevent HIV transmission and strengthen health systems where blood exposure risks exist.
Who is eligible to apply?
Eligibility is broad and includes public and private nonprofits, for-profit organizations (including small businesses and minority or women-owned businesses), universities and colleges, research institutions, hospitals, community-based and faith-based organizations, federally recognized tribal entities and related organizations, and state and local governments or their bona fide agents. Non-U.S. (non-domestic) entities are also eligible.
Are non-U.S. organizations eligible to apply?
Yes. Non-U.S. (non-domestic) entities are listed among eligible applicants.
What documentation is required if applying as a bona fide agent of a state or local government?
If an applicant applies as a bona fide agent of a state or local government, documentation is required as part of the submission: a letter confirming that status.
What kind of organization is CDC looking for through this broad eligibility?
The eligibility breadth reflects CDC’s interest in selecting an organization with strong technical capacity in IPC, clinical quality improvement, training system development, and multi-country program implementation.
What type of award mechanism is this?
This is a cooperative agreement. The opportunity notes that this model generally involves substantial federal involvement and ongoing collaboration between CDC and the recipient during implementation.
When was the opportunity posted and when did it close?
The opportunity was posted on March 15, 2010, with a closing date of May 17, 2010. The archive date is June 16, 2010.
Which CDC office was referenced for questions about accessing the full announcement?
Questions about accessing the full announcement were directed to the CDC Procurement and Grants Office Technical Information Management Section.
What is the intended end result of the funded work?
The award was intended to catalyze practical improvements in clinical safety, translate those improvements into government-owned standards and training, and ultimately reduce infection risks associated with injections and other invasive procedures across targeted Central Asian health systems.
Browse more opportunities from the same category: Health
Next opportunity: University Turbine Systems Research (UTSR) Program
Previous opportunity: San Juan Acequia Rehabilitation ditch de silting, vegetation removal, erosion control, and earthwork preparation
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA PS10 1075
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA PS10 1075) also looked into and applied for these:
| Funding Opportunity |
|---|
| Modeling of Infectious Disease Agent Systems (U01) Apply for RFA GM 11 002 Funding Number: RFA GM 11 002 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| Reproductive Health Apply for CDC RFA DP10 1007E Funding Number: CDC RFA DP10 1007E Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Graduate Psychology Education Program Apply for HRSA 10 069 Funding Number: HRSA 10 069 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Improving the Translation of the Evidence Based Recommendation of Client Reminder/Recall for Childhood Immunization (U01) Apply for RFA IP 10 004 Funding Number: RFA IP 10 004 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $300,000 |
| Providing Quality Comprehensive HIV/AIDS Prevention, Care and Treatment Services in the Federal Republic of Nigeria, Under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA PS10 1076 Funding Number: CDC RFA PS10 1076 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $62,000,000 |
| National Center for Chronic Disease Prevention and Health Promotion, Division of Cancer Prevention and Control Apply for CDC RFA DP10 1003E Funding Number: CDC RFA DP10 1003E Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Implementation of Prevention, Care, and Treatment Programs for Individuals with HIV/AIDS in the Central Asian Republics of Kazakhstan, Kyrgyz Republic, Tajikistan, Turkmenistan and Uzbekistan under the Presidents Emergency Plan for AIDS Relief (PEPFA Apply for CDC RFA PS10 1087 Funding Number: CDC RFA PS10 1087 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Strengthening Pre Service and In Service Training in the Context of Health System Strengthening in Central Asian Republics of Kazakhstan, Kyrgyz Republic, Tajikistan, Turkmenistan, and Uzbekistan Under the President s Emergency Plan for AIDS Relief Apply for CDC RFA PS10 1088 Funding Number: CDC RFA PS10 1088 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $4,000,000 |
| Prevention of HIV Transmission through Strengthening Blood Safety in the Republic of Zimbabwe under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA PS10 10149 Funding Number: CDC RFA PS10 10149 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $1,800,000 |
| Technical Assistance to Strengthen Blood Safety of the Ministry of Health in the Central Asian Republics of Kazakhstan, Kyrgyz Republic, Tajikistan, Turkmenistan, and Uzbekistan Under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA PS10 10104 Funding Number: CDC RFA PS10 10104 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| HIV/AIDS Program Implementation Support Through Local Universities in the Federal Democratic Republic of Ethiopia Under The Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA PS10 10114 Funding Number: CDC RFA PS10 10114 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $100,000 |
| AIDS Education and Training Center (AETC) National Center for Expansion of HIV Care in Minority Communities Building Capacity in Community Health Centers Apply for HRSA 10 121 Funding Number: HRSA 10 121 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| The Role of Cellular Organelles in Alcohol Induced Tissue Injury (R01) Apply for PA 10 085 Funding Number: PA 10 085 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| The Role of Cellular Organelles in Alcohol Induced Tissue Injury (R21) Apply for PA 10 086 Funding Number: PA 10 086 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Stress Pathways in Alcohol Induced Organ Injury and Protection (R21) Apply for PA 10 094 Funding Number: PA 10 094 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Stress Pathways in Alcohol Induced Organ Injury and Protection (R01) Apply for PA 10 093 Funding Number: PA 10 093 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Alcohol Use Disorders Treatment, Services Research, and Recovery (R01) Apply for PA 10 100 Funding Number: PA 10 100 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Alcohol Use Disorders Treatment, Services Research, and Recovery (R21) Apply for PA 10 102 Funding Number: PA 10 102 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Alcohol Use Disorders Treatment, Services Research, and Recovery (R03) Apply for PA 10 101 Funding Number: PA 10 101 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Secondary Analyses of Social and Behavioral Datasets in Aging (R03) Apply for PA 10 139 Funding Number: PA 10 139 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA PS10 1075", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.